Medigen Biotechnology Corp. (3176.TWO)
TWD 26.25
(-8.7%)
TWD 26.25
(-8.7%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.04 Billion TWD | 28.51% |
| 2022 | -1.47 Billion TWD | -249.38% |
| 2021 | 1.45 Billion TWD | 242.45% |
| 2020 | -574.71 Million TWD | -26.32% |
| 2019 | -567.34 Million TWD | 0.3% |
| 2018 | -549.48 Million TWD | -28.15% |
| 2017 | -470.13 Million TWD | 27.33% |
| 2016 | -763.49 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 15.38 Million TWD | 131.71% |
| 2024 Q1 | -95.21 Million TWD | 90.98% |
| 2023 Q3 | -41.29 Million TWD | 86.51% |
| 2023 FY | - TWD | 28.51% |
| 2023 Q1 | -197.07 Million TWD | 71.58% |
| 2023 Q4 | -510.25 Million TWD | -1135.54% |
| 2023 Q2 | -306.08 Million TWD | -55.32% |
| 2022 Q1 | -132.66 Million TWD | -112.91% |
| 2022 FY | - TWD | -249.38% |
| 2022 Q4 | -693.46 Million TWD | -100.08% |
| 2022 Q3 | -346.59 Million TWD | -14.53% |
| 2022 Q2 | -302.61 Million TWD | -128.11% |
| 2021 Q3 | 629.71 Million TWD | 0.0% |
| 2021 FY | - TWD | 242.45% |
| 2021 Q4 | 1.02 Billion TWD | 63.16% |
| 2020 FY | - TWD | -26.32% |
| 2019 FY | - TWD | 0.3% |
| 2018 FY | - TWD | -28.15% |
| 2017 FY | - TWD | 27.33% |
| 2016 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 365.398% |
| Level Biotechnology Inc. | 98.7 Million TWD | 1158.334% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -2234.916% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | -1348.545% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -4039.888% |
| GlycoNex Incorporation | -126.82 Million TWD | -723.656% |
| VBI | -6.97 Million TWD | -14883.046% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | -626.969% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 4889.629% |
| Visgeneer Inc. | 973 Thousand TWD | 107460.534% |
| Mycenax Biotech Inc. | -339.48 Million TWD | -207.708% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 211.549% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 1146.324% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | -5.401% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -60039.206% |
| Enimmune corporation | -228.96 Million TWD | -356.239% |
| TaiRx, Inc. | -208.64 Million TWD | -400.665% |
| CHO Pharma, Inc. | -277.73 Million TWD | -276.126% |
| EirGenix Inc. | -664.4 Million TWD | -57.226% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 1513.48% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 1610.808% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 2.5% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | -823.574% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 3098.502% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | -1575.652% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -3871.932% |
| RBC Bioscience Corporation | 36.54 Million TWD | 2958.287% |
| BiOptic Inc. | 65.03 Million TWD | 1706.166% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | -53.066% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -3064.934% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -1802.245% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 340.942% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -2158.927% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -5793.14% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | -908.173% |
| Neith Corporation | -33.61 Million TWD | -3008.057% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | -1204.598% |
| NaviFUS Corp. | -55.79 Million TWD | -1772.243% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -6193.638% |
| Sinew Pharma Inc. | -163.63 Million TWD | -538.399% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | -1598.566% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 642.935% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | -360.838% |
| AP Biosciences Inc | -325.51 Million TWD | -220.914% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -2814.183% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 3686.056% |
| Intech Biopharm Corporation | -219.58 Million TWD | -375.724% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | -54.935% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -2223.904% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | -549.408% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 259.357% |
| TCI GENE Inc. | 25.98 Million TWD | 4120.7% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | -844.177% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | -268.102% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | -615.639% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 7642.368% |
| PharmaEngine, Inc. | 347.3 Million TWD | 400.777% |
| Savior Lifetec Corporation | 219.6 Million TWD | 575.68% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 706.525% |
| OBI Pharma, Inc. | -855.08 Million TWD | -22.165% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | -1028.548% |
| Acepodia, Inc. | -764.51 Million TWD | -36.637% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | -127.046% |